An involvement of St 155 [2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride, Catapres®] in cholinergic mechanisms

Boissier, 1968, Cardiovascular effects of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride (St 155), European J. Pharmacol., 2, 333, 10.1016/0014-2999(68)90183-0 Graubner, 1966, Kritische Betrachtungen zum Wirkungsmechanismus des 2-(2,6-dichlorophenylamino)-2-imidazolin-hydrochlorids, Arzneim.-Forsch. (Drugs Res.), 16, 1055 Heymans, 1958, Reflexogenic areas of the cardiovascular system, 1 Hoefke, 1966, Pharmakologische Wirkungen des 2-(2,6-dichlorophenylamino)-2-imidazolin-hydrochlorids, einer neuen antihypertensiven Substanz, Arneim.-Forsch. (Drugs Res.), 16, 1038 Kobinger, 1967, Ueber den Wirkungsmechanismus einer neuen antihypertensiven Substanz mit Imidazolinstruktur, Naunyn Schmiedebergs Arch. Pharmakol. Exp. Path., 258, 48, 10.1007/BF00535929 Kobinger, 1967, Kreislaufuntersuchunden mit 2-(2,6-dichlorophenylamino)-2-imidazolin-HCl, Catapresan. St 155. Arzneimittel-Forsch. (Drug Res.), 17, 292 Kobinger, 1967, Investigations into the mechanism of the hypotensive effect of 2-(2,6-dichlorophenylamino)-2-imidazoline-HCl, European J. Pharmacol., 2, 155, 10.1016/0014-2999(67)90080-5 Magnus, 1968, Mechanism of Hypotensive Action of 2-(2,6-dichlorophenylamino)-2-imidazoline-HCl (St 155), Cat. J. Pharm. Sci., 57, 594, 10.1002/jps.2600570409 Rand, 1968, Mechanisms of the pressor and depressor actions of St 155 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride, Catapres®, European J. Pharmacol., 3, 27, 10.1016/0014-2999(68)90044-7 Sattler, 1967, Acute hypotensive action of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride (St 155) after infusion into the cat's vertebral artery, European J. Pharmacol., 2, 9, 10.1016/0014-2999(67)90016-7 Schmitt, 1968, Cardiovascular effects of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride (St 155), European J. Pharmacol., 2, 340, 10.1016/0014-2999(68)90184-2 Sherman, 1968, Evidence for a central hypotensive mechanism of 2-(2,6-dichlorophenylamino)-2-imidazoline (Catapresan, St 155), European J. Pharmacol., 2, 326, 10.1016/0014-2999(68)90087-3